Saturday 17 October 2026 Export TMO’s income statement to Excel — free account

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 9.35%, free cash flow grew 51.8% and total debt rose 18.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

690.00 6.49 −0.93%

Follow TMO

Alert me

Market cap: $257.5B
P/E: 37.1×
Fwd P/E: 23.7×
Dividend yield: 0.27%
F-score: 5/9
Altman Z: 3.84
Beneish M: −2.46
Dividend safety: 88/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Thermo Fisher Scientific Inc. 10-K filed Feb 20, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed Feb 20, 2025 · accepted 1:33 PM ET · Document on sec.gov · Filing index

Thermo Fisher Scientific Inc. 10-K filed Feb 20, 2025

Stockrow Weekly